{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:04:33Z","timestamp":1784099073489,"version":"3.55.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment in older adults with type 2 diabetes mellitus (T2DM) is increasingly recognized, and coronary artery disease (CAD) is also linked to cognitive decline. However, their combined impact remains underexplored. This exploratory study characterized neurocognitive profiles and brain MRI features associated with comorbid CAD in older T2DM patients with cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study screened 1,217 older adults with T2DM; 523 with cognitive impairment (MoCA &amp;lt; 26) were included. All underwent brain MRI and were stratified by CAD status. Between-group comparisons were performed to examine differences in cognitive and neuroimaging measures, with false discovery rate correction applied for multiple comparisons. Multiple linear regression was used to assess the independent association between CAD and cognitive function. Logistic regression was further performed to evaluate the association between CAD and binary neuroimaging outcomes. Finally, two-step cluster analysis was performed to identify distinct cognitive and brain imaging profiles among these participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with T2DM and CAD exhibited higher frequencies of cerebrovascular markers: lacunar infarcts (74.65% vs. 57.10%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), strategic infarcts (32.86% vs. 19.35%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001), and white matter hyperintensities (66.67% vs. 36.77%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), but lower medial temporal lobe atrophy (30.52% vs. 44.52%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001). After false discovery rate correction, these differences remained significant. The CAD group scored lower on MoCA total, visuospatial\/executive function, attention, and orientation. CAD independently predicted lower global cognition (\n                      <jats:italic>B<\/jats:italic>\n                      \u202f=\u202f\u22120.74, 95% CI: \u22121.42 to \u22120.06,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03). Logistic regression further confirmed that CAD was independently associated with higher odds of lacunar infarcts, strategic infarcts, and white matter hyperintensities (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05), but not with medial temporal lobe atrophy (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.518). Cluster analysis revealed distinct profiles: among non-CAD patients, three subgroups (cerebrovascular-predominant, mixed, atrophy-predominant); among CAD patients, two subgroups (both with significant lacunar infarcts, differentiated by atrophy prominence and delayed recall).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In older T2DM patients with cognitive impairment, comorbid CAD was independently associated with a vascular-dominant phenotype. Cluster analysis suggested CAD may modify phenotypic heterogeneity, though these exploratory findings require validation. They provide a hypothesis-generating framework for integrating cardiovascular risk management into cognitive treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1825819","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:05:13Z","timestamp":1784095513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterogeneous cognitive and neuroimaging profiles in older adults with type 2 diabetes: the modifying effect of coronary artery disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Qingjuan","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e70345","DOI":"10.1111\/jcmm.70345","article-title":"Trajectory of cardiogenic dementia: a new perspective","volume":"29","author":"AlRawili","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41583-025-00950-1","article-title":"The vascular contribution to cognitive decline in ageing and dementia","volume":"26","author":"Anderle","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","article-title":"Brain arteriolosclerosis","volume":"141","author":"Blevins","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4239\/wjd.v15.i4.575","article-title":"N\u03b5-carboxymethyl-lysine and inflammatory cytokines, markers and mediators of coronary artery disease progression in diabetes","volume":"15","author":"Eiras","year":"2024","journal-title":"World J. Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"8198","DOI":"10.1002\/alz.14263","article-title":"Current status of professional memory clinics, inpatient services, and health professionals in China","volume":"20","author":"Gan","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/alz.12516","article-title":"Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population","volume":"18","author":"Godrich","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e70436","DOI":"10.1002\/alz.70436","article-title":"The burden of cognitive impairment","volume":"21","author":"Gracner","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.jacc.2025.04.057","article-title":"The impact of cognitive impairment on cardiovascular disease","volume":"85","author":"Jamil","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e031407","DOI":"10.1161\/JAHA.123.031407","article-title":"Association between onset age of coronary heart disease and incident dementia: a prospective cohort study","volume":"12","author":"Liang","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1152\/physrev.00028.2024","article-title":"The pathogenesis of cerebral small vessel disease and vascular cognitive impairment","volume":"105","author":"Markus","year":"2025","journal-title":"Physiol. Rev."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/eurjpc\/zwae153","article-title":"Diabetes and coronary artery disease as risk factors for dementia","volume":"32","author":"Olesen","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"102383","DOI":"10.1016\/j.arr.2024.102383","article-title":"True or false? Alzheimer's disease is type 3 diabetes: evidences from bench to bedside","volume":"99","author":"Peng","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in understanding the pathophysiology of lacunar stroke: a review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.122.063374","article-title":"Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study","volume":"147","author":"Sattar","year":"2023","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/CIRCULATIONAHA.124.070632","article-title":"Genetic and lifestyle risks for coronary artery disease and long-term risk of incident dementia subtypes","volume":"151","author":"Sittichokkananon","year":"2025","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/STROKEAHA.123.040499","article-title":"Cognitive impairment in patients with cardiac disease: implications for clinical practice","volume":"54","author":"van Nieuwkerk","year":"2023","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.str.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s13244-016-0521-6","article-title":"Imaging biomarkers of dementia: recommended visual rating scales with teaching cases","volume":"8","author":"Wahlund","year":"2017","journal-title":"Insights Imaging"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S1474-4422(21)00060-0","article-title":"Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts","volume":"20","author":"Weaver","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jalz.2018.01.007","article-title":"Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis","volume":"14","author":"Wolters","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4899688","DOI":"10.1155\/2021\/4899688","article-title":"Cognitive dysfunction after heart disease: a manifestation of the heart-brain Axis","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1825819\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:05:14Z","timestamp":1784095514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1825819\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":24,"alternative-id":["10.3389\/fnagi.2026.1825819"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1825819","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1825819"}}